• Open Account

Aarti Pharmalabs Ltd

Small Cap  | Pharmaceuticals
₹ 855.5 -23.55(-2.68%)
Last updated: 09-Oct-2026 , 15:59:29
Aarti Pharmalabs Ltd Price Today Aarti Pharmalabs Ltd share price is ₹855.5 as on 09-Oct-2026, Down 2.68% from the previous close of ₹879.05. The stock has traded between ₹892 and ₹850 today, against a 52-week range of ₹585 to ₹1002.4. Over the past year the stock is Up 71.35% range. Market capitalisation stands at ₹8644.96 crore.

Aarti Pharmalabs Ltd Live Price Chart

Performance

Low: ₹850 High: 892
Previous Close ₹ 879.05
High ₹ 892
Volume 444377
52W Range ₹ 585 - ₹ 1002.4
Open ₹ 880.7
Low ₹ 850
Market Cap ₹ 8644.96 Cr

Aarti Pharmalabs Ltd Technicals

Current Price
₹ 855.5 -23.55 (-2.68%)
EMASMA
20 Day ₹ 900.841
50 Day ₹ 849.286
100 Day ₹ 800.219
200 Day ₹ 768.508
20 Day ₹ 892.755
50 Day ₹ 843.603
100 Day ₹ 760.721
200 Day ₹ 739.722

Aarti Pharmalabs Ltd Fundamentals

ROCE 10.127
P/E Ratio 37.290
P/B Ratio 3.920
Industry P/E 3.920
Debt to Equity 49.304
ROE 8.889
EPS 22.950
Dividend Yield 0.410
Book Value 218.611
Face Value 5.000

Aarti Pharmalabs Ltd Financials

Particulars Y202603 Y202503 Y202403 Y202303 Y202203
Total Revenue 1812.8749 1784.1487 1513.141 1512.5291 943.5334
Total Expenses 1575.841 1447.8077 1238.6218 1279.1735 809.8072
Profit After Tax 176.2019 257.3488 200.6454 171.7269 106.7262

Aarti Pharmalabs Ltd Shareholding Pattern

Promoter Holdings 42.857 %
FIIs 8.174 %
DIIs 6.433 %
MutualFund 0.791 %
Retail 34.390 %
Others - 7.355 %

About Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited was initially incorporated as 'Aarti Organics Limited' in 2019. The name of the Company was changed to Aarti Pharmachem Limited in July, 2021 and again to Aarti Pharmalabs Limited in 2022. The Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), CDMO services and Xanthine derivatives situated in India. It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anti-cancer, Anti-Asthma, Anti-Hypertensive etc. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022. In 2021-22, the Pharmaceutical Division was demerged from Aarti Industries Limited into its wholly owned subsidiary, Aarti Pharmalabs Limited, via Scheme of Arrangement for Demerger, thus making it effective on October 17, 2022 and operational from July 1, 2021. Thereafter, Company commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023. The R&D centre in Nerul, Navi Mumbai became fully operational in FY 2024. The Company commenced operations for its semi-com ...

Similar Stocks

Ambalal Sarabhai Enterprises Ltd Pharmaceuticals ₹ 40.59
+0.32 (+0.79%)
Amrutanjan Health Care Ltd Pharmaceuticals ₹ 508.90
+5.85 (+1.16%)
Astrazeneca Pharma India Ltd Pharmaceuticals ₹ 5,837.00
+117.5 (+2.05%)
Bliss GVS Pharma Ltd Pharmaceuticals ₹ 655.95
-11.75 (-1.76%)
Abbott India Ltd Pharmaceuticals ₹ 26,000.00
+420 (+1.64%)
Cipla Ltd Pharmaceuticals ₹ 1,301.00
-5.8 (-0.44%)

FAQs on Aarti Pharmalabs Ltd

1. Can I buy Aarti Pharmalabs Ltd from PL Capital? ›

Yes, you can invest in Aarti Pharmalabs Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Aarti Pharmalabs Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Aarti Pharmalabs Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Aarti Pharmalabs Ltd pay dividends? ›

Yes, Aarti Pharmalabs Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Aarti Pharmalabs Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.

3. What is the current share price of Aarti Pharmalabs Ltd ? ›

As of 09-Oct-2026 , 15:59:29 the share price for Aarti Pharmalabs Ltd. is ₹ 855.5 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Aarti Pharmalabs Ltd ? ›

The 52-week high and low of Aarti Pharmalabs Ltd share price is ₹ 585 - ₹ 1002.4 as of 09-Oct-2026 , 15:59:29 .

5. What is the market capitalisation of Aarti Pharmalabs Ltd? ›

Market capitalisation of Aarti Pharmalabs Ltd is ₹8644.96Cr as of 09-Oct-2026.

6. What is the current P/E ratio of Aarti Pharmalabs Ltd? ›

The P/E (price-to-earnings) ratio of Aarti Pharmalabs Ltd is 37.290.

7. What is the current P/B ratio of Aarti Pharmalabs Ltd? ›

The P/B (price-to-book) ratio of Aarti Pharmalabs Ltd is 3.920.

8. What is the shareholding pattern of Aarti Pharmalabs Ltd? ›

As of 09-Oct-2026, promoters hold 42.857%, foreign institutional investors hold 8.174%, domestic institutional investors hold 6.433%, and the public holds 34.390%.

9. What is the 1-year return of Aarti Pharmalabs Ltd? ›

The 1-year return of Aarti Pharmalabs Ltd is + 71.35%.
Open Your Demat Account
with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges
Start Stock SIP

Start SIP in Aarti Pharmalabs Ltd

Invest systematically in stocks with the
PL Capital app

Get the App
Start SIP mobile app preview
App QR Code

Download the PL Capital App

Open Demat Account
×
I consent to receive calls/messages from PL